like most bills, its a mixed bag..understand House stripped out provision that allowed some under the table relations with physicians..thats good...throwing money at FDA to speed research and approval is also welcome.....letting pharma companies limit disclosure...might be good for business but dont want to be on ass end of that one as a patient....confident Leo et al will skillfully navigate their way through this..go ctix